Back to Search Start Over

Eli Lilly jumps deeper into AI with $409M Genetic Leap deal.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 9/5/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Eli Lilly has vaulted into an AI-enabled drug discovery deal, partnering with RNA specialist Genetic Leap in a pact worth up to $409 million in upfront and milestone payments. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DRUG discovery
ARTIFICIAL intelligence
RNA
PAYMENT

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
179515125

Tools

Authors Abstract Subjects Details